IGF2BP1 and non-small cell lung carcinoma: Low IGF2BP1 expression inhibits cell proliferation and migration but induces cell cycle arrest and apoptosis in NSCLC, and it correlates with a good prognosis (Huang et al., 2019; Huang et al., 2020b; Zhang et al., 2020).